Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Forty Seven Inc stock logo
FTSV
Forty Seven
$95.51
$95.51
$5.53
$95.51
$4.60B0.41.61 million shsN/A
Laurion Mineral Exploration Inc. stock logo
LME
Laurion Mineral Exploration
C$0.33
+1.5%
C$0.35
C$0.32
C$0.51
C$90.25M0.0569,995 shs20,000 shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Forty Seven Inc stock logo
FTSV
Forty Seven
0.00%0.00%0.00%0.00%0.00%
Laurion Mineral Exploration Inc. stock logo
LME
Laurion Mineral Exploration
+1.56%-5.80%-5.80%-16.67%-27.78%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Forty Seven Inc stock logo
FTSV
Forty Seven
N/AN/AN/AN/AN/AN/AN/AN/A
Laurion Mineral Exploration Inc. stock logo
LME
Laurion Mineral Exploration
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Forty Seven Inc stock logo
FTSV
Forty Seven
0.00
N/AN/AN/A
Laurion Mineral Exploration Inc. stock logo
LME
Laurion Mineral Exploration
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Forty Seven Inc stock logo
FTSV
Forty Seven
$15.68M293.33N/AN/A$7.52 per share12.70
Laurion Mineral Exploration Inc. stock logo
LME
Laurion Mineral Exploration
N/AN/AC$0.02 per share16.67C$0.03 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Forty Seven Inc stock logo
FTSV
Forty Seven
-$87.62M-$2.34N/AN/AN/AN/A-50.38%-44.35%N/A
Laurion Mineral Exploration Inc. stock logo
LME
Laurion Mineral Exploration
-C$3.66M-C$0.01N/AN/AN/A-41.39%-30.02%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Forty Seven Inc stock logo
FTSV
Forty Seven
N/AN/AN/AN/AN/A
Laurion Mineral Exploration Inc. stock logo
LME
Laurion Mineral Exploration
N/A5.52%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Forty Seven Inc stock logo
FTSV
Forty Seven
N/A
14.81
14.81
Laurion Mineral Exploration Inc. stock logo
LME
Laurion Mineral Exploration
N/A
20.47
35.69

Institutional Ownership

CompanyInstitutional Ownership
Forty Seven Inc stock logo
FTSV
Forty Seven
71.77%
Laurion Mineral Exploration Inc. stock logo
LME
Laurion Mineral Exploration
N/A

Insider Ownership

CompanyInsider Ownership
Forty Seven Inc stock logo
FTSV
Forty Seven
37.40%
Laurion Mineral Exploration Inc. stock logo
LME
Laurion Mineral Exploration
17.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Forty Seven Inc stock logo
FTSV
Forty Seven
5748.16 millionN/ANot Optionable
Laurion Mineral Exploration Inc. stock logo
LME
Laurion Mineral Exploration
N/A273.50 millionN/ANot Optionable

Recent News About These Companies

Laurion Mineral to Host 2025 Shareholder Meeting

Media Sentiment Over Time

Forty Seven stock logo

Forty Seven NASDAQ:FTSV

Forty Seven Inc., a clinical-stage immuno-oncology company, focuses on developing therapies to activate macrophages for the treatment of cancer. It is developing 5F9, a humanized IgG4 subclass monoclonal antibody against CD47 that is in Phase 1b/2 clinical trials used for the treatment of cancer; FSI-189, an antibody that binds to SIRPa; and FSI-174, an anti-cKIT antibody. Forty Seven Inc. has a collaboration agreement with Genentech to include third clinical trial in non-Hodgkin's lymphoma. The company was formerly known as CD47 Sciences, Inc. Forty Seven Inc. was incorporated in 2014 and is headquartered in Menlo Park, California.

Laurion Mineral Exploration stock logo

Laurion Mineral Exploration CVE:LME

C$0.33 +0.01 (+1.54%)
As of 03:17 PM Eastern

Laurion Mineral Exploration Inc. engages in the acquisition, exploration, and development of mineral properties in Canada. It explores for gold, silver, zinc, copper, and other base metal deposits. The company's flagship property is the Ishkoday property covering an area of 57.43 square kilometer located in Irwin, Pifher, Walters, and Elmhirst townships, Thunder Bay Mining Division. The company was formerly known as Laurion Gold Inc. and changed its name to Laurion Mineral Exploration Inc. in October 2006. Laurion Mineral Exploration Inc. was incorporated in 1945 and is based in Toronto, Canada.